Clinical Trials Directory

Trials / Completed

CompletedNCT03193879

Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma

Effects of Particulate Matter on the Lung Function and Acute Exacerbation of COPD and Asthma Patients--A Multi-center Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
505 (actual)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a variety of respiratory diseases, including COPD and asthma. This study focus on the effects of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China, where PM exposure is much heavier than the United States and European countries.

Detailed description

Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a variety of respiratory diseases, including COPD and asthma. This study focus on the effects of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China, where PM exposure is much heavier than the United States and European countries. This study is an observational study which lasts 3 years. Primary outcome measures:Change in spirometry (FEV1) of COPD, asthma patients and healthy volunteers in response to different exposure doses of PM.

Conditions

Timeline

Start date
2015-12-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2017-06-21
Last updated
2021-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03193879. Inclusion in this directory is not an endorsement.